Petmed Express Inc: Form 10-K for the period ended Mar 31, 2025
Filed with the SEC on Oct 14, 2025 and accepted by EDGAR at Oct 14, 2025, 16:27 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2024-04-01 to 2025-03-31 | $227.0m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2024-04-01 to 2025-03-31 | $157.8m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months2024-04-01 to 2025-03-31 | $69.1m | us-gaap:GrossProfit |
| Operating income | 12 months2024-04-01 to 2025-03-31 | −$1.5m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2024-04-01 to 2025-03-31 | $5.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2024-04-01 to 2025-03-31 | −$6.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2024-04-01 to 2025-03-31 | −$0.30 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2024-04-01 to 2025-03-31 | −$0.30 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2024-04-01 to 2025-03-31 | 20,596,022 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2024-04-01 to 2025-03-31 | $4.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2024-04-01 to 2025-03-31 | $5.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2024-04-01 to 2025-03-31 | $181.0k | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | At period end2025-03-31 | $54.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-03-31 | $78.9m | us-gaap:AssetsCurrent |
| Total assets | At period end2025-03-31 | $148.7m | us-gaap:Assets |
| Current liabilities | At period end2025-03-31 | $62.8m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-03-31 | $63.6m | us-gaap:Liabilities |
| Shareholders' equity | At period end2025-03-31 | $85.1m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001040130-25-000072. Last ingested by Listed: Oct 24, 2026, 15:04 ET. Listed shows no prices and gives no investment advice.